13,075‑Share Notice: AS (NYSE: AS) Form 144 Sale Filing
Rhea-AI Filing Summary
AS reports intent to sell 13,075 Ordinary shares under Rule 144. The shares were purchased 02/01/2024 pursuant to a directed share program in connection with the issuer's initial public offering and a sale date of 02/07/2024 is shown. The filing lists Morgan Stanley Smith Barney LLC and indicates cash as the consideration.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 13,075 shares
Acquisition date: 02/01/2024
Shown sale date: 02/07/2024
+1 more
4 metrics
Shares to be sold
13,075 shares
listed on Form 144
Acquisition date
02/01/2024
purchased pursuant to a directed share program
Shown sale date
02/07/2024
date shown in the securities sold section
Filing/record date
06/01/2026
date listed alongside NYSE in header
Key Terms
directed share program, initial public offering, Form 144
3 terms
initial public offering financial
"in connection with the Issuer?s initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does AS's Form 144 report?
It reports an intent to sell 13,075 Ordinary shares. The shares were purchased on 02/01/2024 under a directed share program tied to the issuer's IPO, and the filing shows a sale date of 02/07/2024 with cash consideration.
Who is listed as the broker or intermediary on the AS Form 144?
Morgan Stanley Smith Barney LLC is listed as the broker/intermediary. The filing shows the firm's address at 1 New York Plaza, 8th Floor, New York, NY, and associates that broker with the securities to be sold on the Form 144.